Correlation Between Femasys and Neuropace
Can any of the company-specific risk be diversified away by investing in both Femasys and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Femasys and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Femasys and Neuropace, you can compare the effects of market volatilities on Femasys and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Femasys with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Femasys and Neuropace.
Diversification Opportunities for Femasys and Neuropace
Excellent diversification
The 3 months correlation between Femasys and Neuropace is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Femasys and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Femasys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Femasys are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Femasys i.e., Femasys and Neuropace go up and down completely randomly.
Pair Corralation between Femasys and Neuropace
Given the investment horizon of 90 days Femasys is expected to generate 6.0 times less return on investment than Neuropace. But when comparing it to its historical volatility, Femasys is 1.38 times less risky than Neuropace. It trades about 0.03 of its potential returns per unit of risk. Neuropace is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 739.00 in Neuropace on September 1, 2024 and sell it today you would earn a total of 321.00 from holding Neuropace or generate 43.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Femasys vs. Neuropace
Performance |
Timeline |
Femasys |
Neuropace |
Femasys and Neuropace Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Femasys and Neuropace
The main advantage of trading using opposite Femasys and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Femasys position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.Femasys vs. Precision Optics, | Femasys vs. Repro Med Systems | Femasys vs. InfuSystems Holdings | Femasys vs. Utah Medical Products |
Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bonds Directory Find actively traded corporate debentures issued by US companies |